framycetin has been researched along with rifamycins in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (28.13) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 13 (40.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Postle, DS; Poutrel, B; Roguinsky, M | 1 |
| Calzetti, C; Fiaccadori, F; Missale, G; Pedretti, G | 1 |
| Falcioni, E; Mignini, F; Prenna, M; Ripa, S | 1 |
| Marchi, E; Venturini, AP | 1 |
| Blamire, J; Flechtner, VR; Sager, R | 1 |
| Ghione, M | 1 |
| Wagman, GH; Weinstein, MJ | 1 |
| Vogt, E | 1 |
| Brogden, RN; Gillis, JC | 1 |
| Ferrieri, A; Miglio, F; Rossellini, SR; Valpiani, D | 1 |
| Gorbacheva, VA; Luchikhin, LA; Magomedov, MM | 1 |
| Allerberger, F; Calabrò, GB; Gaion, RM; Miglioli, PA | 1 |
| Baliasinskaia, GL | 1 |
| HEJZLAR, M; JELINEK, J; VYMOLA, F | 1 |
| BRETTE, R; LEVRAT, M; TRUCHOT, R | 1 |
| Finegold, SM; Molitoris, D; Väisänen, ML | 1 |
| Córdoba Cardona, J; García Martínez, R | 1 |
| Shaikh, OS; Sundaram, V | 1 |
| Mohammed, F | 1 |
| Hua, J; Hwang, L; Low, K; Morales, W; Pimentel, M; Zhu, A | 1 |
| Brawner, WR; Faircloth, J; Jahraus, CD; Powell, C; Ramos, M; Rynders, P; Schemera, B | 1 |
| Gerharz, CD; Gillmann, A; Müssig, K | 1 |
| Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
| Alaniz, C; Mohammad, RA; Regal, RE | 1 |
| Gao, J; Gillilland, M; Kao, JY; Owyang, C; Song, I; Wu, X; Xu, D | 1 |
| Kamath, PS; Kim, WR; Leise, MD; Poterucha, JJ | 1 |
| Cash, BD | 1 |
| Amichai, M; Chang, C; Chua, KS; DiBaise, J; Mirocha, J; Pimentel, M; Rao, S | 1 |
| Antoniazzi, BF; Bresolin, CR; Pires, CW; Praetzel, JR; Weiss, RN | 1 |
| Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, LR; Zheng, MH; Zhu, GQ | 1 |
| Cross, TJ; Ellul, MA; Gholkar, SA | 1 |
| Bridgeman, MB; Dixit, D; Jawaro, T; Yang, A | 1 |
12 review(s) available for framycetin and rifamycins
| Article | Year |
|---|---|
Antibiotic from Micromonospora.
Topics: Aminoglycosides; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Dactinomycin; Erythromycin; Gentamicins; Glycosides; Lactams, Macrocyclic; Leucomycins; Neomycin; Pyrrolidines; Rifamycins; Sisomicin; Streptomycetaceae | 1980 |
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.
Topics: Diarrhea; Diverticulum, Colon; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Paromomycin; Rifamycins; Rifaximin | 1995 |
[Update on the management of hepatic encephalopathy].
Topics: Aged; Ammonia; Anti-Bacterial Agents; Antidotes; Clinical Trials as Topic; Dialysis; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Liver Transplantation; Meta-Analysis as Topic; Neomycin; Protein Synthesis Inhibitors; Rifamycins; Risk Factors | 2008 |
Hepatic encephalopathy: pathophysiology and emerging therapies.
Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc | 2009 |
[Diagnostics and treatment of hepatic encephalopathy].
Topics: Anti-Infective Agents; Cytokines; Diagnosis, Differential; Disaccharides; Event-Related Potentials, P300; Flicker Fusion; Hepatic Encephalopathy; Humans; Liver Function Tests; Neomycin; Neurologic Examination; Prognosis; Reactive Oxygen Species; Rifamycins; Rifaximin; Risk Factors | 2012 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
Combination therapy for the treatment and prevention of hepatic encephalopathy.
Topics: Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Probiotics; Rifamycins; Rifaximin | 2012 |
Management of hepatic encephalopathy in the hospital.
Topics: Disease Management; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Metronidazole; Neomycin; Protein Synthesis Inhibitors; Recurrence; Rifamycins; Rifaximin; Terminology as Topic | 2014 |
Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
Topics: Adult; Anti-Infective Agents; Humans; Irritable Bowel Syndrome; Neomycin; Probiotics; Rifamycins; Rifaximin; Treatment Outcome | 2014 |
Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Dipeptides; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Mental Health; Neomycin; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2015 |
Hepatic encephalopathy due to liver cirrhosis.
Topics: Albumins; Amino Acids; Diagnosis, Differential; Diet; Disaccharides; Drug Resistance; Electroencephalography; Glycerol; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Neomycin; Neurologic Examination; Nucleic Acid Synthesis Inhibitors; Ornithine; Phenylbutyrates; Probiotics; Protein Synthesis Inhibitors; Rifamycins; Rifaximin; Terminal Care; Tomography, X-Ray Computed | 2015 |
Management of Hepatic Encephalopathy: A Primer.
Topics: Anti-Bacterial Agents; Disaccharides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Metronidazole; Neomycin; Practice Guidelines as Topic; Probiotics; Rifamycins; Rifaximin; Severity of Illness Index | 2016 |
5 trial(s) available for framycetin and rifamycins
| Article | Year |
|---|---|
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
Topics: Aged; Ammonia; Chronic Disease; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Neomycin; Prospective Studies; Rifamycins; Rifaximin | 1991 |
Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.
Topics: Administration, Oral; Adult; Aged; Ammonia; Anti-Bacterial Agents; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Intestinal Absorption; Male; Middle Aged; Neomycin; Neuropsychological Tests; Rifamycins; Rifaximin | 1997 |
[Efficiency of otoph and polydex ear drops in otitis treatment].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Dexamethasone; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neomycin; Otitis; Polymyxin B; Rifamycins; Severity of Illness Index; Treatment Outcome | 1999 |
[Ear drops otofa and polydexa for treatment of acute external otitis media in children].
Topics: Acute Disease; Administration, Topical; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Dexamethasone; Drug Combinations; Humans; Infant; Infant, Newborn; Neomycin; Otitis Externa; Polymyxin B; Rifamycins | 2003 |
Antibiotic treatment of constipation-predominant irritable bowel syndrome.
Topics: Adult; Anti-Infective Agents; Breath Tests; Constipation; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Male; Methane; Middle Aged; Neomycin; Rifamycins; Rifaximin | 2014 |
15 other study(ies) available for framycetin and rifamycins
| Article | Year |
|---|---|
Treatment during lactation of induced and naturally occurring staphylococcal infections of the bovine.
Topics: Animals; Cattle; Cephapirin; Cloxacillin; Female; Lactation; Leucomycins; Mastitis, Bovine; Neomycin; Penicillins; Pregnancy; Rifamycins; Staphylococcal Infections; Staphylococcus aureus | 1979 |
In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.
Topics: Campylobacter; Clostridium; Microbial Sensitivity Tests; Neomycin; Rifampin; Rifamycins; Rifaximin; Yersinia | 1987 |
In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin.
Topics: Administration, Oral; Animals; Bacteria; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Escherichia coli; Injections; Male; Mice; Microbial Sensitivity Tests; Neomycin; Rifampin; Rifamycins; Rifaximin; Staphylococcus aureus | 1986 |
Regulation of nuclear DNA replication by thechloroplast in Chlamydomonas.
Topics: Adenine; Cell Nucleus; Cells, Cultured; Centrifugation, Density Gradient; Cesium; Chlamydomonas; Chloramphenicol; Chloroplasts; Clindamycin; Densitometry; DNA; DNA Repair; DNA Replication; Neomycin; Rifamycins; Spectinomycin; Streptomycin; Tritium | 1974 |
Antibiotics in the chemotherapy of amebiasis.
Topics: Amebiasis; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Gentamicins; Humans; Neomycin; Novobiocin; Paromomycin; Penicillins; Polymyxins; Rifamycins; Streptomycin; Tetracyclines | 1984 |
[Effects of rifamycin SV and a neomycin-bacitracin combination on the healing of microbial eczema].
Topics: Adult; Aged; Bacitracin; Drug Combinations; Eczema; Female; Humans; Male; Middle Aged; Neomycin; Rifamycins | 1983 |
Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Colony Count, Microbial; Drug Administration Schedule; Feces; Male; Neomycin; Rats; Rats, Wistar; Rifamycins; Rifaximin | 2001 |
[RAPID DETERMINATION OF THE SENSITIVITY OF BACTERIA TO ANTIBIOTICS].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Colistin; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Kanamycin; Methicillin; Neomycin; Oleandomycin; Oxacillin; Paromomycin; Penicillin G; Polymyxins; Research; Rifamycins; Staphylococcus; Streptomycin; Tetracycline; Tetrazolium Salts; Vancomycin | 1963 |
[THE BILIARY ELIMINATION OF ANTIBIOTICS].
Topics: Anti-Bacterial Agents; Bacitracin; Bile; Biliary Tract; Chloramphenicol; Dogs; Erythromycin; Hepatobiliary Elimination; Liver; Liver Diseases; Neomycin; Novobiocin; Oleandomycin; Penicillins; Polymyxins; Research; Rifamycins; Spiramycin; Streptomycin; Tetracycline | 1964 |
Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
Topics: Ampicillin; Bacteria, Anaerobic; Feces; Microbial Sensitivity Tests; Neomycin; Nitro Compounds; Rifamycins; Rifaximin; Sulbactam; Teicoplanin; Thiazoles; Vancomycin | 2009 |
Alcoholic hepatitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Hepatic Encephalopathy; Hepatitis, Alcoholic; Humans; Neomycin; Rifamycins; Rifaximin; Treatment Failure | 2009 |
A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Irritable Bowel Syndrome; Male; Methane; Middle Aged; Neomycin; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome | 2010 |
Rifaximin diminishes neutropenia following potentially lethal whole-body radiation.
Topics: Animals; Anti-Infective Agents; Body Weight; Dose-Response Relationship, Drug; Female; Leukocyte Count; Neomycin; Neutropenia; Radiation Injuries, Experimental; Rats; Rats, Wistar; Rifamycins; Rifaximin; Whole-Body Irradiation | 2010 |
Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.
Topics: Administration, Oral; Animals; Biomarkers; Blotting, Western; Cytokines; DNA, Bacterial; Drug Administration Schedule; Gastrointestinal Agents; Hyperalgesia; Ileitis; Ileum; Immunohistochemistry; Intestinal Mucosa; Male; Microbiota; Neomycin; Occludin; Rats; Rats, Wistar; Restraint, Physical; Reverse Transcriptase Polymerase Chain Reaction; Rifamycins; Rifaximin; Sequence Analysis, DNA; Stress, Psychological | 2014 |
Antimicrobial activity of different filling pastes for deciduous tooth treatment.
Topics: Analysis of Variance; Anti-Bacterial Agents; Bacitracin; Bacteria; Chlorhexidine; Drug Combinations; Fluprednisolone; Microbial Sensitivity Tests; Neomycin; Ointments; Polymyxin B; Prednisolone; Reproducibility of Results; Rifamycins; Root Canal Filling Materials; Statistics, Nonparametric; Time Factors; Tooth, Deciduous | 2015 |